Skip to main content
. 2020 Dec 12;25(24):5880. doi: 10.3390/molecules25245880

Table 1.

The molecular mechanisms involved in manganese (Mn)-induced toxicity in various neural cell types such as microglia, astrocytes, and neurons and in multiple regions of the brain.

Experimental Model Species Mn (Dosage/Concentration) Cytotoxicity Mechanisms Disease Model References
Neural cell type
Microglia Mouse (N9), Mouse (BV2) MnCl2 (50–1000 µM) ↑TNF-α, ↑ILs, ↑interferons ↑NF-κB activation Mn toxicity [93,125,128]
Microglia Mouse (N9), Rat MnCl2 (30 µM) ↑TNF-α, ↑IL-1β Mn toxicity [125,127]
Microglia Human (HMC3) MnCl2 (250 µM) ↑LRRK2 expression and kinase activity
↑ROS, ↑TNF-α, ↑apoptosis
Mn toxicity [131]
Astrocytes Mice MnCl2 (0.1–10 µM) ↑Cyclooxygenase 2, ↑iNOS, ↑NF-κB activation, ↑inflammation Mn toxicity [118,120,121,122]
Astrocytes Mouse MnCl2 (50 µM) ↑Inflammation, ↑iNOS, ↑NO Mn toxicity [123]
Astrocytes Rat, Mice MnCl2 (5, 50 µM) ↑TNF-α, ↑IL-1β, ↑iNOS Mn toxicity [20,118,124,125,126]
Astrocytes Rat, Human MnCl2 (250 µM) ↓Glutamate reuptake, ↓EAAT1/GLAST, ↓EAAT2/GLT-1, ↑YY1, ↑HDAC-YY1 interaction Mn toxicity [149,150]
Astrocytes Rat MnCl2 (100–200 µM) ↓Glutamate reuptake, ↓SOD activity, ↓GPx activity, ↑LDH release, ↑IL-6 Mn toxicity [99]
Astrocytes Rat MnCl2 (100, 500, 1000 µM) ↑F2-isoprostanes, ↑lipid peroxidation Mn toxicity [107]
Astrocytes Human (U87) MnCl2 (400, 800, 2000 µM) ↓Glutathione Mn toxicity [100]
Neurons
Cortical Neuron rat MnCl2 (500 µM) ↑ROS production, ↑F2-isoprostanes, ↓ATP production Mn toxicity [22]
Dopaminergic Human (SH-SY5Y) MnCl2 (800 µM) ↑ROS production, ↑lipid peroxidation, ↓ATP levels, ↓mitochondrial membrane potential Mn toxicity; PD [101]
Dopaminergic Human (SH-SY5Y) MnCl2 (2–125 µM) ↑DNA damage, ↑oxidative stress Mn toxicity; PD [23]
Dopaminergic Rat (N27) MnCl2 (300 µM) ↑Cytochrome c release, ↑caspase-3 activation, ↑DNA damage, ↑ROS, ↑apoptosis, ↑αSyn aggregation Mn toxicity [94]
Dopaminergic Rat (N27) MnCl2 (10–5000 µM) ↑ROS, ↑mitochondria damage, ↑apoptosis, ↑PKCδ activation Mn toxicity [95,96]
Catecholaminergic/Dopaminergic Mouse (CAD), Human (LUHMES) MnCl2 (250 µM) ↓TH, ↓REST, ↓NRF2, ↓catalase, ↓HO-1
↑oxidative stress, ↑inflammation
Mn toxicity; PD [8]
Dopaminergic Rat (PC12) MnCl2 (100 µM) ↑TH phosphorylation, ↑cytotoxicity Mn toxicity; PD [141]
Dopaminergic C. elegans MnCl2 (40 mM) ↑oxidative stress Mn toxicity; PD [98]
Cholinergic Mouse (SN56) MnCl2 (1–200 µM) ↑Aβ peptides misfolding and aggregation AD [179]
Neuron Mouse, Rat MnCl2 (100, 500, 1000 µM) ↑F2-isoprostanes, ↑lipid peroxidation Mn toxicity [106]
Neuron Rat (PC12) MnCl2 (100–500 µM) ↑Tau phosphorylation, ↑impaired tau degradation/aggregation, ↑ERK/GSK-3β activation, ↑cytotoxicity AD [180]
Dopaminergic Rat (MES 23.5) MnCl2 (200–600 µM) ↑αSyn levels, ↑p38 activation, ↑NF-κB activation, ↑NO, ↑apoptosis Mn toxicity; PD [167]
Organotypic Brain Slices Rat MnCl2 (400 µM) ↑ROS, ↑apoptosis, ↑LDH release, ↓SOD activity, ↑αSyn levels Mn toxicity; PD [166]
Dopaminergic Human (SH-SY5Y) MnCl2 (500 µM) ↑Apoptosis, ↑caspase 3, ↑αSyn levels Mn toxicity; PD [169]
Dopaminergic Mouse (MN9D) MnCl2 (300 μM) ↑Exosome release, ↑cytotoxicity, ↑Rab27a Mn toxicity [172]
Dopaminergic Human (LUHMES), Mouse (MN9D) MnCl2 (10 mM) ↑αSyn misfolding, ↑αSyn release, ↑inflammation Mn toxicity [173]
Brain regions
Striatum, brain stem Rat MnCl2 (25 mg/kg) ↓Glutathione synthesis, ↓energy
↑hypoxanthine, ↑xanthine, ↑uric acid
[102]
Basal ganglia Human NA ↑Astrogliosis Mn toxicity; PD [117]
Basal ganglia (Striatum); Substantia nigra Rat (neonate, adult) MnCl2 (10 mg/kg) ↓DA levels Mn toxicity; PD [132,133]
Striatum Rat Mn (100 mg/kg) ↓DA levels and stores, ↓DA turnover, ↓DA release, ↑behavioral deficits Mn toxicity; PD [134,135,136]
Globus pallidus (Striatum), Midbrain Human NA ↑Mn levels, ↓DA transporter Mn toxicity [111]
Striatum Rat MnCl2 (5–20 mg/kg, daily, 20 d) ↑Motor deficits, ↑oxidative stress Mn toxicity; PD [21]
Striatum Rat MnCl2 (0.5–2 µmol/µL) ↑Excitotoxic lesions; ↑oxidative stress, ↑mitochondrial impairment Mn toxicity [146]
Striatum Rat MnCl2 (1 mg/mL) ↓ChAT, ↓ACh levels, Mn toxicity [155]
Striatum Mouse MnCl2 (50, 100, and 200 μmol/kg) ↑Autophagy dysregulation, ↑cell injury. ↑αSyn Mn toxicity; PD [168]
Hippocampus Mouse MnCl2 (100 µmol/kg, 5×/week, 6 weeks) ↑Impaired NMDA phosphorylation, ↑memory dysfunction, ↑αSyn dysregulation Mn toxicity; AD [148]
Whole brain Rat MnCl2 (30 mg/kg) ↓AChE, ↑oxidative and nitrosative stress, ↑intracellular Ca2+ accumulation Mn toxicity [154]
Whole brain Rat MnCl2 (3 mg/mL) ↓GABA, ↑seizure duration, ↓seizure threshold Mn toxicity [25]
Forebrain Rat MnCl2 (10 mM) ↓GABA uptake Mn toxicity [159]
Thalamus Rat MnCl2 (1 g/L) ↑GABA Mn toxicity [160]
Substantia nigra Mouse MnCl2 (30 mg/kg, daily/3 wks) ↓TH, ↓EAAT1/GLAST, ↓EAAT2/GLT-1, ↑YY1, ↑HDAC-YY1 interaction, ↑motor deficits, ↑microglial activation Mn toxicity; PD [8]
Midbrain, cerebellum Mouse MnCl2 (10 mg/mL) ↓ChAT, ↑impaired choline uptake Mn toxicity; encephalopathy [156]
Hippocampus, cortex, and basal ganglia Rat MnCl2 ↓Choline transporter, ↓choline uptake, ↓homovanillic acid Mn toxicity [157]
Prefrontal cortex Mouse MnCl2 (5 mg/kg, daily/22 d) ↓ACh activity, ↓nicotinic ACh receptors, ↑impaired spatial memory Mn toxicity; AD [158]
Frontal Cortex Nonhuman primate Mn (3.3–5.0, 5.0–6.7, 8.3–10 mg Mn/kg) ↑αSyn aggregation, ↑apoptosis Mn toxicity; PD [165]
Frontal cortex Nonhuman primate NA ↑Aβ precursor protein 1, ↑Aβ expression, ↑cytotoxicity AD [176,177]
Parietal cortex Human NA ↑Mn levels, ↑AD pathology, ↑impaired Aβ and ApoE function AD [174]
Cerebral cortex, hippocampus Mouse MnCl2 (0.36 mg/mL, 5 mos.) ↑Aβ expression, ↑β- and γ-secretase cleavage activities AD [178]
Blood Human NA ↑Mn levels, ↑impaired Aβ degradation/aggregation, ↑cognitive impairment AD [175]

↑: increased. ↓: decreased. NA, not applicable/not available. CAD: Cath.a differentiated. LRRK2: leucine rich repeat kinase 2. LUHMES: Lund human mesencephalic. TNF-α: tumor necrosis factor alpha. NF-κB: nuclear factor kappa-light-chain enhancer of B cells. IL-1β: interleukin 1β. IL-6: interleukin 6. iNOS: inducible nitric oxide synthase. NO: nitric oxide SOD: superoxide dismutase. GPx: glutathione peroxidase. LDH: lactate dehydrogenase. ROS: reactive oxygen species. EAAT1/2: excitatory amino acid transporter 1/2. GLAST: glutamate aspartate transporter 1. GLT: glutamate transporter 1 PKC: protein kinase C. GSH: glutathione. NRF2: Nuclear factor erythroid 2-related factor 2. HO-1: Heme oxygenase-1. REST: repressor element-1 silencing transcription factor. TH: tyrosine hydroxylase. DA: dopamine. αSyn: α-synuclein. Aβ: amyloid-β. ApoE: apolipoprotein E. ChAT: choline acetyltransferase. ACh: acetylcholine. GABA: gamma aminobutyric acid. ERK: extracellular signal-regulated kinase: GSK-3β: HDAC: histone deacetylase. YY1: Yin Yang 1. NMDA: N-methyl D-aspartate. PD: Parkinson’s disease. AD: Alzheimer’s disease.